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Editorial on the Research Topic
Macromolecular Structure Underlying Recognition in Innate Immunity
Our innate immune system has evolved to distinguish between self, non-self, altered self, and 
intrinsic as well as extrinsic danger signals. Recognition is mediated via interactions between 
pattern recognition receptor molecules (PPRs) and their ligands, which include hydrophobic and 
electrostatic interactions between amino acid residues on the PPRs and uncharged or charged groups 
on amino acid residues, sugar rings, or DNA/RNA molecules. These PRRs can be phagocytic, sen-
sors, and humoral. Recognition in innate immunity can involve interaction between many ligands 
with one receptor molecule, and the density and the number of glycans, charge patterns or epitopes 
dictate a strong and specific recognition, distinct from weak non-specific binding (1). In the case of 
toll-like receptors (TLRs) and nucleotide-binding oligomerization domain-like receptors (NLRs), 
the ligand recognition is followed by oligomerization of the receptor molecules. This special topic 
issue has made an effort to somewhat highlight the complexity of such biological interactions and 
their, sometimes unexpected, consequences.
Bessa Pereira et al. have taken up the case of a scavenger receptor, SSc5D, which belongs to the 
scavenger receptor cysteine-rich (SRCR) family, and have made an effort to localize domains involved in 
pathogen-associated molecular patterns (PAMPs) recognition. SRCR proteins can be membrane-bound 
or secreted that contain type I macrophage scavenger receptor domain/s. SSc5D is a soluble SRCR com-
posed of an N-terminal, five SRCR domains (N-SSc5D) and a C-terminal mucin-like domain. Based 
on surface plasmon resonance-measurements of interaction kinetics, N-SSc5D was found to have a 
better ability to bind Escherichia coli strains RS218 and IHE3034, and Listeria monocytogenes. This 
paper speculates on the importance of differential SRCR binding on the strain specificity. An associated 
commentary on this paper by Lozano and Martínez-Florensa, however, sounds a cautionary note on 
the interpretation of the data, especially with respect to CD6 that does not seem to be functional in the 
studies by Bessa Pereira et al. The scientific exchange between the two research groups (Lozano and 
Martínez-Florensa; Oliveira and Carmo) raises an important issue that a number of variations reported 
in the literature could owe to the design of the constructs and choice of domains used.
The study and critique on SRCR (Bessa Pereira et al.; Lozano and Martínez-Florensa; Oliveira 
and Carmo) are followed by some excellent, though diverse, papers that highlight the importance of 
understanding protein–ligand and protein–protein interactions in innate and adaptive immunity. 
Two papers (Hellmuth et al.; Wan et al.) dwell upon the modalities of modulating intracellular PRRs 
(sensors) and their immunological consequences. Hellmuth et  al. have made a synthetic bid to 
impede TLR7 activation by conjugating single-stranded RNA (ssRNA for TLR7 stimulation), small 
molecules TLR7 agonists (smTLRa for immune potentiation of candidate vaccines), and an interfer-
ence RNA (siRNA). Contrary to an expected synergistic effect, the authors reported a reduced TLR7 
activation and encouraged the notion of shielding effect of the conjugates on TLR7 stimulation 
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(Hellmuth et al.). Wan et al. have examined, using a grass carp 
model, downstream signaling and interferon (IFN) response 
involving two intracellular sensors: retinoic acid-inducible 
gene I (RIG-I) and melanoma differentiation-associated gene 
5 (MDA5). Following grass carp reovirus infection, MDA5 
induced an elaborate type I IFN response; both MDA5 and 
RIG-I facilitated the total phosphorylation levels of IFN regula-
tory factor (IRF) 3 and 7 (IRF7). Whereas MDA5 enhanced the 
heterodimerization of IRF3 and IRF7 and homodimerization of 
IRF7, RIG-I facilitated the heterodimerization and attenuated 
IRF7 homodimerization. The consequence of this differential 
multimerization renders MDA5 a more effective modulator of 
IFN response compared to RIG-1 (Wan et  al.). In an exciting 
paper on zebrafish innate immunity, García-Valtanen et al. have 
investigated, via transcriptomics and immunohistochemistry, 
the immune responses of Rag1 gene knock-out (−/−) phenotype 
(zebrafish deficient in its adaptive immune wing) to Spring 
Viremia Carp Virus (SVCV) infection. Remarkably, Rag1−/− 
zebrafish showed resistance to SVCV in an age-dependent 
manner, compared to their Rag1+/+ counterparts. The analysis 
of the microarray data revealed that genes related to apoptotic 
functions, immune-related multigene families, and IFN-related 
components were constitutively upregulated in adult Rag1−/− 
zebrafish, thus preparing the host for the impending pathogen 
insult. In addition, in the absence of T and B cell functions, the 
Rag1−/− mice relied heavily on the infiltration of macrophages 
and natural killer cells, and IFNs for achieving a sustainable 
anti-viral state (García-Valtanen et al.; García-Valtanen et al.). 
Next, Kajla et al. report that heme peroxidase HPX15, which is 
found in the midgut of mosquito Anopheles stephensi, encour-
ages development of Plasmodium parasite by suppressing local 
immune mechanisms. The orthologs of HPX15 are absent in 
non-Anopheles mosquitoes, insects, or human. Silencing of this 
gene via iRNA reduced the midgut parasite load in the mosquito, 
suggesting that interference with HPX15 gene can be exploited 
to contain the Plasmodium within the vector and minimize its 
dissemination.
There are five papers that take up a range of issues related to 
two key complement proteins, C1q and properdin. C1q is the first 
subcomponent of the complement classical pathway that binds to 
IgG or IgM containing immune complexes and a number of self 
and non-self target ligands via its globular (gC1q) domain. The 
gC1q domain is located C-terminal to a triple-helical collagen-
like domain, which offers sites for interaction with C1r and C1s 
subcomponents, in addition to binding to its putative receptors, 
including calreticulin-CD91 complex (2). C1q is a versatile soluble 
charge pattern recognition molecule of the innate immunity. The 
gC1q domain is a heterotrimeric structure, which is composed of 
C-terminal ends of the three chains of C1q (A, B, and C chains). 
Individually expressed globular head (gh) modules of the three 
chains (ghA, ghB, and ghC) have been functionally characterized 
previously (3), which established the concept of structural and func-
tional modularity within the heterotrimeric structure of the gC1q 
domain. However, in this volume, generation of a recombinant form 
of heterotrimeric gC1q domain is being reported by Gaboriaud 
et al. using a mammalian expression system (Moreau et al.), which 
is functionally active and its crystal structure mirrors that of the 
native gC1q domain generated via collagenase digestion of an 
intact human C1q molecule. Thus, this recombinant gC1q domain 
can be of great help in basic and clinical research on human C1q, 
in addition to being an excellent reagent/tool for the complement 
research community. On the continuing theme of gC1q domain, 
Pednekar et  al. have examined the nature of interaction of the 
recombinant ghA, ghB, and ghC modules as well their substitution 
mutants with a gC1q putative receptor molecule, gC1qR. Another 
paper examines interaction between dendritic cell-specific inter-
cellular adhesion molecule-3-grabbing non-integrin (DC-SIGN; 
CD209), C1q and gC1qR, and its implication on HIV-1 infection 
(Pednekar et  al.). It sheds an interesting light on host–pathogen 
interaction involving three immune molecules and one pathogen 
component. C1q, by virtue of its ability to bind DC-SIGN, appears 
to suppress DC-SIGN mediated transfer of HIV-1 to CD4+ T cells 
while gC1qR appears to enhance trans-infection, raising the pos-
sibility that HIV-1 may recruit/exploit gC1qR in order to negate the 
protective effect of C1q (Pednekar et al.).
The final two papers in this issue report pattern recognition 
properties of human properdin, an upregulator of the comple-
ment alternative pathway. Properdin stabilizes C3bBb convertase 
in the alternative pathway, and its functions have largely been 
considered to be reliant on C3b deposition on the complement-
activating surfaces (4). However, there are recent evidences 
to suggest that local production of properdin by immune cells 
including dendritic cells, neutrophils, and T cells may be geared 
at complement-independent functions of properdin. Kouser et al. 
report that human properdin can opsonize nanoparticles using its 
thrombospondin repeats 4 and 5 (TSR4 + 5) and mount a robust 
pro-inflammatory immune response via recruitment of NF-κB. 
One of the major findings reported in this paper is that a recom-
binant form of TSR4 + 5, expressed in tandem and coated on the 
nanoparticles, can act as an inhibitor of the alternative pathway, 
thus paving a way forward for in vivo preclinical trials of such 
nanoparticles for dampening exaggerated complement activation 
in a range of disease models (5; Kouser et al.). Al-Mozaini et al. 
have examined complement-independent interaction between 
human properdin and Mycobacterium bovis BCG. Contrary to 
their behavior when coated on nanoparticles, properdin, and 
recombinant TSR4  +  5 appear to exert an anti-opsonic effect 
on M. bovis BCG, thus, reducing micro-organism uptake by 
phagocytic cells (Al-Mozaini et  al.). These two papers (Kouser 
et al.; Al-Mozaini et al.) appear to highlight that properdin can 
act as a soluble PRR, it does not always require the availability 
of C3b bound to target ligands, and that properdin on its own 
can modulate local inflammatory response. However, in the case 
of nanoparticles, properdin seems to enhance phagocytosis; 
whereas in the case of M. bovis BCG, it appears to reduce uptake: 
a contrasting and intriguing set of observations. Clearly, specific 
ligands need to be identified on Mycobacterium whose masking by 
properdin may interfere with surface receptors on macrophages 
that are used by this pathogen to enter its intracellular habitat.
aUtHor CoNtriBUtioNS
UK reflected on the papers published within the volume and 
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